120 related articles for article (PubMed ID: 37823184)
1. Do age at diagnosis, tumour thickness and tumour site explain sex differences in melanoma survival? A causal mediation analysis using cancer registry data.
Afshar N; Dashti SG; Mar V; Te Marvelde L; Evans S; Milne RL; English DR
Int J Cancer; 2024 Mar; 154(5):793-800. PubMed ID: 37823184
[TBL] [Abstract][Full Text] [Related]
2. Factors Explaining Socio-Economic Inequalities in Survival from Colon Cancer: A Causal Mediation Analysis.
Afshar N; Dashti SG; Te Marvelde L; Blakely T; Haydon A; White VM; Emery JD; Bergin RJ; Whitfield K; Thomas RJS; Giles GG; Milne RL; English DR
Cancer Epidemiol Biomarkers Prev; 2021 Oct; 30(10):1807-1815. PubMed ID: 34272266
[TBL] [Abstract][Full Text] [Related]
3. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
[TBL] [Abstract][Full Text] [Related]
4. Comparison of anatomical locations of cutaneous melanoma in men and women: a population-based study in France.
Chevalier V; Barbe C; Le Clainche A; Arnoult G; Bernard P; Hibon E; Grange F
Br J Dermatol; 2014 Sep; 171(3):595-601. PubMed ID: 24725117
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Sex-Specific Incidence of Melanoma.
Olsen CM; Thompson JF; Pandeya N; Whiteman DC
JAMA Dermatol; 2020 May; 156(5):553-560. PubMed ID: 32211827
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
7. Skin melanoma deaths within 1 or 3 years from diagnosis in Europe.
Sacchetto L; Rosso S; Comber H; Bouchardy C; Broganelli P; Galceran J; Hackl M; Katalinic A; Louwman M; Robsahm TE; Tryggvadottir L; Tumino R; Van Eycken E; Walsh PM; Zadnik V; Zanetti R
Int J Cancer; 2021 Jun; 148(12):2898-2905. PubMed ID: 33497469
[TBL] [Abstract][Full Text] [Related]
8. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population?
Dal H; Boldemann C; Lindelöf B
Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388
[TBL] [Abstract][Full Text] [Related]
9. Melanoma in older patients: declining gap in survival between younger and older patients with melanoma.
Schuurman MS; Hollestein LM; Bastiaannet E; Posthuma EFM; van Akkooi AJC; Kukutsch NA; Aarts MJB; Wakkee M; Lemmens VEPP; Louwman MWJ
Acta Oncol; 2020 Jan; 59(1):4-12. PubMed ID: 31347929
[No Abstract] [Full Text] [Related]
10. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.
Chamberlain AJ; Fritschi L; Giles GG; Dowling JP; Kelly JW
Arch Dermatol; 2002 May; 138(5):609-14. PubMed ID: 12020221
[TBL] [Abstract][Full Text] [Related]
11. Differences in cancer survival by area-level socio-economic disadvantage: A population-based study using cancer registry data.
Afshar N; English DR; Blakely T; Thursfield V; Farrugia H; Giles GG; Milne RL
PLoS One; 2020; 15(1):e0228551. PubMed ID: 31999795
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous melanoma in Iceland: changing Breslow's tumour thickness.
Stefansson H; Tryggvadottir L; Olafsdottir EJ; Mooney E; Olafsson JH; Sigurgeirsson B; Jonasson JG
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):346-352. PubMed ID: 24909543
[TBL] [Abstract][Full Text] [Related]
13. 'Get Data Out' Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England.
van Bodegraven B; Vernon S; Eversfield C; Board R; Craig P; Gran S; Harwood CA; Keohane S; Levell NJ; Matin RN; Proby C; Rajan N; Rous B; Ascott A; Millington GWM; Venables ZC;
Br J Dermatol; 2023 May; 188(6):777-784. PubMed ID: 36814132
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
Beaudoux O; Riffaud L; Barbe C; Grange F
Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
17. Season of diagnosis has no effect on survival from malignant melanoma.
Jayasekara H; Karahalios E; Thursfield V; Giles GG; English DR
Int J Cancer; 2009 Jul; 125(2):488-90. PubMed ID: 19391134
[TBL] [Abstract][Full Text] [Related]
18. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
19. Differences in cancer survival by sex: a population-based study using cancer registry data.
Afshar N; English DR; Thursfield V; Mitchell PL; Te Marvelde L; Farrugia H; Giles GG; Milne RL
Cancer Causes Control; 2018 Nov; 29(11):1059-1069. PubMed ID: 30194549
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
